cyclin A2 Activators
Cyclin A2 is a pivotal protein that plays a critical role in the regulation of the cell cycle. As part of the cyclin family, cyclin A2 interacts with specific cyclin-dependent kinases (CDKs) to form complexes that are essential for cell cycle progression. In particular, cyclin A2 is associated with the transition from the G1 phase to the S phase and is also involved in the progression through the G2 phase. Its expression levels are meticulously controlled within the cell, reflecting its importance in ensuring accurate DNA replication and division. Cyclin A2 is not uniformly expressed throughout the cell cycle; rather, its levels peak during the S phase and the early G2 phase, following which it is targeted for degradation as the cell transitions into mitosis. The regulated expression and destruction of cyclin A2 are crucial for the cell cycle's fidelity and timing, which are indispensable for maintaining cellular homeostasis and function.
Several chemicals have been identified that can potentially induce the expression of cyclin A2, thereby influencing cell cycle dynamics. Retinoic acid, for instance, is known to modulate gene expression by binding to retinoic acid receptors, which can lead to an upregulation of cyclin A2 and other cell cycle-related genes. Forskolin, by increasing intracellular cAMP levels, can activate protein kinase A and subsequently enhance the transcriptional activity of genes involved in cell cycle control. Dexamethasone, interacting with glucocorticoid receptors, may trigger an increase in cyclin A2 expression by modulating transcription factors that are critical for cell cycle governance. Histone deacetylase inhibitors such as Trichostatin A and sodium butyrate can lead to a more accessible chromatin structure and thus facilitate the transcription of cyclin A2. Additionally, DNA methyltransferase inhibitors like 5-Azacytidine can reactivate epigenetically silenced genes, potentially increasing cyclin A2 expression. Understanding these activators and their mechanisms offers insight into the complex regulation of the cell cycle.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to retinoic acid receptors, initiating transcription of target genes, including those governing the cell cycle. This binding may specifically upregulate cyclin A2 expression to facilitate cell cycle progression into the S phase. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP, which activates protein kinase A. This kinase can phosphorylate transcription factors, leading to the transcriptional activation of cell cycle-related genes, including cyclin A2, thus potentially increasing its expression to promote cell division. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone interacts with glucocorticoid receptors to activate specific gene expression. This glucocorticoid can trigger an upregulation of cyclin A2 expression by engaging with transcription factors that govern cell cycle control, particularly in cells of the immune system. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, a kinase that normally suppresses certain growth-stimulatory pathways. The inhibition of GSK-3 by lithium may result in an elevation of cyclin A2 expression, which is a central component for cell cycle progression, especially in neuronal cells. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, by inhibiting histone deacetylases, allows for a more open chromatin state and transcriptional activation. This may lead to the enhanced transcription of cyclin A2, effectively increasing its expression levels to drive cells through key cell cycle checkpoints. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As a histone deacetylase inhibitor, sodium butyrate promotes acetylation of histones, leading to a relaxed chromatin structure and active transcription. This can stimulate the expression of genes like cyclin A2, which is necessary for the G1 to S phase transition in the cell cycle. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, can induce demethylation of gene promoter regions, reactivating epigenetically silenced genes. This demethylation may lead to the reactivation and increased expression of cyclin A2, particularly in the context of cell cycle re-entry and progression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin specifically inhibits mTORC1, a central regulator of cell growth. This inhibition frequently leads to a compensatory upregulation of other pathways that stimulate cell cycle progression, potentially including an increase in cyclin A2 expression to maintain cellular proliferation under stress. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin induces DNA damage, which can initiate a DNA damage response leading to cell cycle arrest. This response often includes the upregulation of cell cycle proteins like cyclin A2 as the cell attempts to repair the damage before proceeding through the cell cycle checkpoints. | ||||||